Cargando…
Overexpression of Hepatocyte Chemerin-156 Lowers Tumor Burden in a Murine Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma
The tumor inhibitory potential of the highly active chemerin-156 isoform was described in orthotopic models of hepatocellular carcinoma (HCC). The majority of HCC arises in the fibrotic liver, which was not reproduced in these studies. Here, a potential therapeutic activity of chemerin-156 was evalu...
Autores principales: | Haberl, Elisabeth M., Pohl, Rebekka, Rein-Fischboeck, Lisa, Feder, Susanne, Sinal, Christopher J., Bruckmann, Astrid, Hoering, Marcus, Krautbauer, Sabrina, Liebisch, Gerhard, Buechler, Christa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982125/ https://www.ncbi.nlm.nih.gov/pubmed/31905933 http://dx.doi.org/10.3390/ijms21010252 |
Ejemplares similares
-
Hepatocyte expressed chemerin-156 does not protect from experimental non-alcoholic steatohepatitis
por: Pohl, Rebekka, et al.
Publicado: (2022) -
Chemerin Overexpression in the Liver Protects against Inflammation in Experimental Non-Alcoholic Steatohepatitis
por: Pohl, Rebekka, et al.
Publicado: (2022) -
Accumulation of cholesterol, triglycerides and ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice
por: Haberl, Elisabeth M., et al.
Publicado: (2021) -
Variations in hepatic lipid species of age-matched male mice fed a methionine-choline-deficient diet and housed in different animal facilities
por: Rein-Fischboeck, Lisa, et al.
Publicado: (2019) -
Chemerin Isoform-Specific Effects on Hepatocyte Migration and Immune Cell Inflammation
por: Feder, Susanne, et al.
Publicado: (2020)